These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20589414)

  • 41. A low pH form of thiamine pyrophosphatase from bovine brain.
    Castner JF; Evans HJ
    Neurosci Lett; 1977 Apr; 4(5):269-73. PubMed ID: 19604957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ig-like Domain in Endoglucanase Cel9A from Alicyclobacillus acidocaldarius Makes Dependent the Enzyme Stability on Calcium.
    Pazhang M; Younesi FS; Mehrnejad F; Najavand S; Tarinejad A; Haghi M; Rashno F; Khajeh K
    Mol Biotechnol; 2018 Sep; 60(9):698-711. PubMed ID: 30062637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
    Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase.
    Bielohuby M; Popp S; Bidlingmaier M
    Mol Metab; 2012; 1(1-2):47-60. PubMed ID: 24024118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
    Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
    Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of 3'-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism.
    Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):35-42. PubMed ID: 9512094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribozyme-mediated cleavage of a substrate analogue containing an internucleotide-bridging 5'-phosphorothioate: evidence for the single-metal model.
    Kuimelis RG; McLaughlin LW
    Biochemistry; 1996 Apr; 35(16):5308-17. PubMed ID: 8611518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.
    Koziołkiewicz M; Wójcik M; Kobylańska A; Karwowski B; Rebowska B; Guga P; Stec WJ
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):43-8. PubMed ID: 9055038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of divalent cations on the formation and stability of myosin subfragment 1-ADP-phosphate analog complexes.
    Peyser YM; Ben-Hur M; Werber MM; Muhlrad A
    Biochemistry; 1996 Apr; 35(14):4409-16. PubMed ID: 8605190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of divalent cations on the catalytic activity of the human plasma 3'-exonuclease.
    Wojcik M; Stec WJ
    Biometals; 2010 Dec; 23(6):1113-21. PubMed ID: 20589414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of phosphorothioate oligonucleotides with stereodefined phosphorothioate linkages.
    Guga P; Stec WJ
    Curr Protoc Nucleic Acid Chem; 2003 Oct; Chapter 4():Unit 4.17. PubMed ID: 18428907
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.